Bionano Genomics, Inc. — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2021-04-01

Reporting Person: Holmlin R. Erik (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Option (Right to Buy)	$7.83	A	775000	Acquired	2031-03-31	Common Stock (775000)	Direct

Footnotes

F1: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of April 1, 2021 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.